To all shareholders and employees,

Today, February 5, 2022, is a day of milestone for Orient Gene (Orient Gene 688298), which is the$ second anniversary of being listed on SSE STAR. On behalf of the Boa↓rd of Directors and management of the company, we wish you a happy Spring Festival, safe♣ and healthy!

Over the past two years since the availability on the market, we have mad e full use of our technological and product advantages, adhered to the principle of qual↕ity first, and actively devoted ourselves to the global fight againλst COVID-19. After experiencing numerous tests and trials, the company has also enjoyed✔ rapid growth.

We have achieved a qualitative leap in molecular cloning and genetic engineering te∞chnology; Our products on three platforms including immunochromatogr aphy, molecular diagnosis and liquid chip underwent constant iterative upgrade and in>novation; Our enterprise grew bigger and bigger, with more and more standardized internal governanc e, more and more leading figures and professional talents.

We also took a solid step in global layout. Healgen, a wholly-owned subsidi♣ary located in Houston, with rapid development, has basicaλlly formed a diversified development pattern of R&D, production, sales and third-p←arty testing. The subsidiary in Vancouver, Canada, has enjoyed steadyλ development. Alco Biotechnology, a new company established in Scotland, is expec>ted to be officially put into production and operation in about a month; We☆ set up Qikang Capital in Hainan, which is a preliminary attempt to promote the good and σstandardized development of enterprises through the capital market; W¶e have set up sales centers in Shanghai, Shenzhen, Hangz×hou and Houston. Our high-quality products are continuously sold to more than 120 co✔untries and regions around the world, reaching the front line o©f global health care and epidemic containment, and playing a™n important role; We have prepared and set up Wanzijian medical testing centers andβ testing platforms in Shanghai, Hainan and Beijing; The ≈development model of the combination of industrial service and t rade has begun to take shape.

We have made closer and closer cooperation with Siemens, Mckess§on, CVS, Walmart, Walgreen and other customers, with continuously expanded influenc e of the brands Orient Gene and Healgen in the dom estic and foreign markets. We have donated a series of anti-epidemic products at home ≈and abroad, and funded a number of schools and students, ‌playing our part in social responsibility. We received support and help from t§he governments of China and other countries in our anti-epidemic actions and marketin£g operations, as well as the support and assistance from tens of thousands of emp☆loyees from various places，and they worked together with us. Besides, we won great trus♦t and support of all shareholders, who were always ∏by our side, and tided over the difficulties together.

With a heart of gratitude, we will work harder and lead Orient £Gene to strive to overcome all kinds of difficulties and solve all kinds of problems,× so that the enterprise can stand among the world's great enterprises in the future!